Get started
Atossa Therapeutics, Inc.Atossa Therapeutics, Inc.Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

ATOS chart

Key stats

Market capitalization
‪192.97 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.24USD
Net income
‪−30.09 M‬USD
Revenue
—
Shares float
‪125.25 M‬
Beta (1Y)
1.39

About Atossa Therapeutics, Inc.

Sector
Health Technology
CEO
Steven C. Quay
Headquarters
Seattle
Website
atossatherapeutics.com
Employees (FY)
12
Founded
2008
ISIN
US04962H5063
FIGI
BBG002NCD8C8
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where ATOS is featured.

See all sparks 

Frequently Asked Questions

The current price of ATOS is 1.35 USD — it has decreased by 12.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Atossa Therapeutics, Inc. stocks are traded under the ticker ATOS.
Atossa Therapeutics, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Atossa Therapeutics, Inc. has a max estimate of 4.00 USD and a min estimate of 4.00 USD.
ATOS earnings for the last quarter are −0.05 USD whereas the estimation was −0.07 USD which accounts for 25.00% surprise. Estimated earnings for the next quarter are −0.06 USD. See more details about Atossa Therapeutics, Inc. earnings.
Yes, you can track Atossa Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ATOS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Atossa Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ATOS reached its all-time high on Mar 19, 2013 with the price of 2231.78 USD, and its all-time low was 0.50 USD and was reached on Dec 28, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 12.00 employees. See our rating of the largest employees — is Atossa Therapeutics, Inc. on this list?